News - Legal, Novartis

Filter

Current filters:

LegalNovartis

Popular Filters

1 to 25 of 30 results

Novartis subject to Italian investigation over alleged vaccine fraud

Novartis subject to Italian investigation over alleged vaccine fraud

23-06-2014

Swiss drug maker Novartis is the subject of a new investigation by Italian authorities. The company’s…

Health Medical PharmaInfluenzaItalyLegalMedicineNovartisPharmaceuticalPharmacologyVaccines

Roche and Novartis fined for cartelizing sales of eye drugs Avastin and Lucentis in Italy

Roche and Novartis fined for cartelizing sales of eye drugs Avastin and Lucentis in Italy

06-03-2014

Swiss pharma majors Roche and Novartis colluded to exclude the cheaper cancer drug Avastin (bevacizumab),…

AvastinEuropeFinancialItalyLegalLucentisNovartisOphthalmicsPharmaceuticalRoche

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

10-01-2014

Swiss drug major Novartis faced two problems yesterday, when the Japanese Ministry of Health Labor and…

Asia-PacificCardio-vascularDiovanExjadeHematologyLegalMarkets & MarketingNorth AmericaNovartisPharmaceuticalUSA

Report looks at impact of new law governing clinical trials in Switzerland

Report looks at impact of new law governing clinical trials in Switzerland

15-11-2013

Clinical trials in Switzerland have been the subject of a new report carried out by the Swiss Federal…

Basilea PharmaceuticaEli LillyEuropeLegalNovartisPharmaceuticalResearchRoche

Sandoz appeals US court decision on AzaSite patent

Sandoz appeals US court decision on AzaSite patent

06-11-2013

US ophthalmic care specialist InSite Vision says that Sandoz Inc, the US generics unit of Swiss drug…

AzaSiteGenericsInSite VisionLegalNorth AmericaNovartisOphthalmicsPatentsSandoz

Novartis under investigation for manipulating data in Japanese clinical trials

Novartis under investigation for manipulating data in Japanese clinical trials

27-09-2013

Swiss drug major Novartis has said it regrets the inconvenience caused by its investigator-initiated…

Asia-PacificCardio-vascularLegalNovartisPharmaceuticalRegulationvalsartan

Novartis charged with paying "kickbacks" to US doctors

29-04-2013

The US Department of Justice announced last Friday (April 26) that the government has filed a second…

LegalMarkets & MarketingNorth AmericaNovartisPharmaceutical

India's Supreme Court denies Novartis Glivec patent appeal

02-04-2013

In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

Italy's antitrust body investigating Roche and Novartis for alleged cartel

21-02-2013

The Italian antitrust authority has opened a cartel investigation of Swiss drug majors Novartis (NOVN:…

AvastinBiotechnologyEuropeGenentechLegalLucentisNovartisOphthalmicsPharmaceuticalRoche

EU Commission sends antitrust complaint to Johnson & Johnson and Novartis

01-02-2013

The European Commission has informed US health care giant Johnson & Johnson (NYSE: JNJ) and Swiss drug…

DuragesicEuropefentanylGenericsJanssen-CilagJohnson & JohnsonLegalMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalSandoz

Novartis Indian patent hearings close, but no verdict yet

05-12-2012

After more than 12 weeks of hearings in India's Supreme Court, humanitarian aid agency Medecins Sans…

Asia-PacificGlivecLegalNovartisPatentsPharmaceutical

MSF update on Novartis versus India, Supreme Court case

18-11-2012

Humanitarian health organization Medecins Sans Frontieres (MSF) says it continues to follow progress…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

US FTC puts divestment conditions on Watson's acquisition of Actavis

16-10-2012

The USA's Federal Trade Commission will require Watson Pharmaceuticals (NYSE: WPI) and fellow generic…

ActavisGenericsLegalMergers & AcquisitionsNorth AmericaNovartisPar PharmaceuticalsSandozWatson Pharmaceuticals

India's patent laws under pressure, say UK researchers

11-09-2012

In a special report in the prestigious medical journal The Lancet, researchers from Queen Mary, University…

Asia-PacificBayerEuropeGenericsLegalNovartisPatentsPharmaceutical

Indian Supreme Court hearing of Novartis vs India patent case delayed again

23-08-2012

Humanitarian organization Medecins Sans Frontieres (MSF) said yesterday that it has learnt that the Indian…

Asia-PacificLegalNovartisPatentsPharmaceutical

Sanofi moves on Lemtrada; Novartis Indian patent case

21-08-2012

French drug major Sanofi's (Euronext: SAN) USA-based rare diseases subsidiary Genzyme is pulling leukemia…

Asia-PacificCampathEuropeGenzymeGlivecLegalLemtradaMarkets & MarketingNorth AmericaNovartisPatentsPharmaceuticalSanofi

Alabama Supreme Court ruling favors Sandoz in Medicaid pricing case

16-07-2012

The USA's Alabama Supreme Court came out in favor of Sandoz, the generics subsidiary of Swiss drug major…

GenericsLegalNorth AmericaNovartisPricingSandoz

Novartis Indian Supreme Court hearings again re-scheduled

09-07-2012

Humanitarian aid agency Medecins Sans Frontieres said on Friday it has learnt that final arguments in…

Asia-PacificGenericsGleevecGlivecLegalNovartisPatentsPharmaceutical

Novartis posts sharp drop in 1st-qtr profit; challenges UK off-label Avastin use

24-04-2012

Swiss drug major Novartis (NOVN: VX) has reported a sharp fall in first-quarter 2012 profits, due in…

AvastinEuropeFinancialGenericsLegalLucentisNovartisOphthalmicsPharmaceutical

1 to 25 of 30 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top